Raia Drogasil S.A. (OTCMKTS:RADLY – Get Free Report) was the target of a significant decrease in short interest in September. As of September 15th, there was short interest totaling 1,765 shares, a decrease of 42.8% from the August 31st total of 3,087 shares. Currently, 0.0% of the shares of the stock are sold short. Based on an average daily trading volume, of 185,484 shares, the days-to-cover ratio is currently 0.0 days.
Raia Drogasil Stock Performance
Shares of RADLY stock remained flat at $3.32 during trading hours on Thursday. 60,116 shares of the company’s stock traded hands, compared to its average volume of 141,854. The stock has a market capitalization of $4.37 billion and a P/E ratio of 66.40. Raia Drogasil has a 52-week low of $3.08 and a 52-week high of $5.34. The stock has a 50-day simple moving average of $3.68 and a 200 day simple moving average of $3.90. The company has a quick ratio of 0.58, a current ratio of 1.41 and a debt-to-equity ratio of 0.99.
Raia Drogasil (OTCMKTS:RADLY – Get Free Report) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $0.05 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.05. Raia Drogasil had a net margin of 2.97% and a return on equity of 18.20%. The firm had revenue of $2.17 billion during the quarter, compared to analyst estimates of $2.32 billion. Equities analysts anticipate that Raia Drogasil will post 0.17 EPS for the current year.
Raia Drogasil Company Profile
Raia Drogasil SA, known as RD Saúde, is a Brazilian healthcare and pharmacy retail company. It operates a nationwide network of drugstores under the Raia and Drogasil brands, offering prescription medicines, over-the-counter products, vitamins, personal-care items, cosmetics and other health-related merchandise.
The company also provides digital shopping and delivery services through its online channels, supporting customers with prescription fulfillment and access to pharmacy products.
See Also
- Five stocks we like better than Raia Drogasil
- Hobby Boom or Travel Bust? Here Are 3 Stocks to Ride the Trend
- Jabil’s Double-Beat and Raise Is a Signal That This Rally Will Continue
- Anthropic’s IPO Could Put Amazon’s and Alphabet’s Paper Profits to the Test
- Microsoft’s AI Spending Didn’t Change—Wall Street’s View of It Did
Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.
